G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	101.36	152.59	139.68	114.75	12.28	14.46
Short-Term Investments	351.9	256.29	173.24	91.2	96.6	105.6
Cash & Short-Term Investments	453.26	408.87	312.92	205.95	108.88	120.06
Cash Growth	39.84%	30.66%	51.94%	89.15%	-9.31%	-4.76%
Accounts Receivable	25.98	17.8	14.78	0.75	5.09	6.09
Other Receivables	0.21	0.16	0.15	0.02	0.03	0.04
Receivables	26.19	17.96	14.93	0.77	5.12	6.13
Inventory	24.95	21.71	22.9	24.64	19.83	16.98
Prepaid Expenses	2.06	2.38	1.41	1.32	2.07	2.97
Total Current Assets	506.46	450.92	352.17	232.69	135.9	146.14
Property, Plant & Equipment	370.49	372.31	375.12	375.15	382.85	389.74
Other Intangible Assets	133.03	133.33	133.89	134.68	135.51	136.11
Long-Term Deferred Tax Assets	0.26	0.26	19.65	37.95	37.59	39.26
Other Long-Term Assets	1.58	2.37	2.27	2.31	0.28	0.48
Total Assets	1,012	959.17	883.1	782.78	692.13	711.73
Accounts Payable	9.43	8.34	4.03	8.97	2.73	3.16
Accrued Expenses	14.81	17.72	17.34	8.11	1.64	1.56
Current Portion of Leases	0.89	0.88	0.69	-	-	-
Current Income Taxes Payable	10.07	3.1	-	-	-	-
Current Unearned Revenue	59.43	85.23	95.24	71.85	0.45	0.17
Other Current Liabilities	52.1	9.51	1.28	2.82	3.85	3.5
Total Current Liabilities	146.72	124.77	118.57	91.74	8.68	8.39
Long-Term Leases	0.42	0.87	1.29	-	-	-
Long-Term Deferred Tax Liabilities	0.06	-	-	0.2	-	-
Total Liabilities	147.21	125.64	119.86	91.94	8.68	8.39
Common Stock	590	590	556.6	556.6	556.6	556.6
Additional Paid-In Capital	134.24	134.24	134.24	273.33	273.33	273.33
Retained Earnings	140.36	109.3	72.4	-139.09	-146.47	-126.59
Shareholders' Equity	864.6	833.53	763.24	690.84	683.45	703.34
Total Liabilities & Equity	1,012	959.17	883.1	782.78	692.13	711.73
Total Debt	1.31	1.75	1.98	-	-	-
Net Cash (Debt)	451.95	407.13	310.94	205.95	108.88	120.06
Net Cash Growth	40.39%	30.93%	50.98%	89.15%	-9.31%	-4.76%
Net Cash Per Share	7.08	6.38	4.88	3.23	1.71	1.88
Filing Date Shares Outstanding	59	63.72	63.72	63.72	63.72	63.72
Total Common Shares Outstanding	59	63.72	63.72	63.72	63.72	63.72
Working Capital	359.73	326.14	233.6	140.95	127.22	137.75
Book Value Per Share	14.65	13.08	11.98	10.84	10.73	11.04
Tangible Book Value	731.57	700.21	629.34	556.16	547.95	567.23
Tangible Book Value Per Share	12.40	10.99	9.88	8.73	8.60	8.90
Land	148.59	148.59	148.59	148.59	148.59	148.59
Buildings	233.75	233.58	233.58	233.08	233.39	233.31
Machinery	52.35	50.77	52.08	55.06	55.32	57.12
Construction In Progress	2.59	2.39	-	-	-	-
Leasehold Improvements	5.33	5.33	5.33	5.33	5.33	5.33

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.